No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Bevacizumab / therapeutic use
-
Canada
-
Diabetic Retinopathy / drug therapy
-
Drug Utilization / trends*
-
Health Care Surveys
-
Humans
-
Macular Edema / drug therapy*
-
Practice Patterns, Physicians' / statistics & numerical data*
-
Ranibizumab / therapeutic use
-
Receptors, Vascular Endothelial Growth Factor / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Retinal Vein Occlusion / drug therapy
-
Surveys and Questionnaires
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
-
Wet Macular Degeneration / drug therapy
Substances
-
Angiogenesis Inhibitors
-
Recombinant Fusion Proteins
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Bevacizumab
-
Receptors, Vascular Endothelial Growth Factor
-
Ranibizumab